May 8, 2008
Biotech Stocks to Watch: Amylin Pharmaceuticals, Gilead...
Amylin Pharmaceuticals Ammending Pact with Eli Lilly Concerning U.S. Marketing; Gilead Sciences CEO John Martin Takes on Additional Duties as Board Chairman; Novartis to Buy Another 214K Addtional Unregistered ... via ClipSyndicate
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 39 min | Dick In Ohio | 685 |
| Claims administrator: Interim payments in $4.85... | 42 min | Dick In Ohio | 1049 |
| MPI Research cutting jobs in Mattawan | 6 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 6 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 9 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 9 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 11 hr | Anon Amous | 3 |
